Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (1): 63-64.
HUANG Xiaomei, NING Junkai, DAI Xubo*
Received:2018-10-25
Revised:2019-02-18
Online:2019-01-20
Published:2019-02-18
CLC Number:
HUANG Xiaomei, NING Junkai, DAI Xubo. One Case of Fanconi Syndrome and Low Phosphorus Osteomalacia Induced by Adefovir Dipivoxil Capsules[J]. Chinese Journal of Pharmacovigilance, 2019, 16(1): 63-64.
Add to citation manager EndNote|Ris|BibTeX
| [1] 周岳进,郑金莉,肖扬,等.国产阿德福韦酯治疗突变的慢性乙型肝炎疗效观察[J].东南国防医药,2006,8(5):330-331. [2] 田月洁,王金英,谢彦军,等.阿德福韦酯治疗乙肝致低血磷骨软化症的现状分析[J].中国药物警戒,2013,10(5):294-298. [3] 邱婷婷,张弨,陈丁丁. 6例药源性肾损伤案例报告及临床分析[J].临床药物治疗杂志,2017,15(6):63-68. [4] 党中勤,谢莉,袁帅强,等.乙肝患者长期服用阿德福韦酯致继发性范可尼综合征1例报道及预防[J].中医临床研究,2017,9(19):58-59. [5] 国家食品药品监督管理局.药品不良反应信息通报(第64期):警惕阿德福韦酯的低磷血症及骨软化风险[EB/OL].(2014-12-10) [2018-01-12].http://www.sda.gov.cn/WS01/CL0051/110621.html. [6] 张楠,邵明玮,黄爱,等.阿德福韦酯致低磷性骨软化症6例分析[J].中华内分泌代谢杂志,2013,29(5):414-416. [7] 刘莎,吴明,刘增娟.长期服用阿德福韦酯片致骨软化症1例[J].中国药物警戒,2017,14(9):570-571. [8] 孙晓方,张化冰,李新萍,等.阿德福韦酯导致低血磷性骨软化症一例并文献复习[J].中华内科杂志,2011,50(9):754-757. [9] 张帅,房舒舒,曹国颖.阿德福韦酯治疗乙肝致低磷血症及骨软化症文献汇总及数据分析[J].中国新药杂志,2015,24(15):1795-7800. [10] 邹羽真,胡扬,张波.阿德福韦酯致范可尼综合征1例及41例不良反应报道汇总分析[J].临床药物治疗杂志,2015,13(2):68-73. [11] 谢莉莉,田月洁,谢彦军,等.160例阿德福韦酯不良反应特征及骨软化的风险因素分析[J]. 中国药物警戒,2015,12(8):487-490. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
